Fig. 3.
Fig. 3. Accelerated differentiation of RARα−/− granulocytes in liquid cultures stimulated with G-CSF and SCF. / Cultures of CFSE-labeled BM cells were harvested 3 days after their initiation and stained for Mac-1 and GR-1 expression. The RAR antagonist BMS493 or the RXR/RAR agonist 9C-RA was added at the onset of the culture at a final concentration of 10−6 M, where indicated. (A) The analysis was limited to CFSElow cells, which correspond to cells that have arisen during the culture from proliferation of immature granulocytes. Note that CFSEhighcells correspond exclusively to mature granulocytes with a Mac-1highGR-1high phenotype (data not shown). (B) Representative GR-1/Mac-1 profiles of CFSElow cells. Note the shift toward the more immature phenotype in the BMS493-treated WT sample and the similarity of the phenotypes of all RARα−/− samples with that of the 9C-RA–treated WT sample. (C) Quantification in percent of all cells present in gates B and C of immature (gate B in panel A) and mature (gate C in panel A) cells from the experiment displayed in panel B. The experiment described in this figure was performed in duplicate for each of the 2 WT and 2 RARα−/− mice. For a given set of culture conditions and mouse genotype, variations in the percentage of the gated populations were within 1.5% of those indicated.

Accelerated differentiation of RARα−/− granulocytes in liquid cultures stimulated with G-CSF and SCF.

Cultures of CFSE-labeled BM cells were harvested 3 days after their initiation and stained for Mac-1 and GR-1 expression. The RAR antagonist BMS493 or the RXR/RAR agonist 9C-RA was added at the onset of the culture at a final concentration of 10−6 M, where indicated. (A) The analysis was limited to CFSElow cells, which correspond to cells that have arisen during the culture from proliferation of immature granulocytes. Note that CFSEhighcells correspond exclusively to mature granulocytes with a Mac-1highGR-1high phenotype (data not shown). (B) Representative GR-1/Mac-1 profiles of CFSElow cells. Note the shift toward the more immature phenotype in the BMS493-treated WT sample and the similarity of the phenotypes of all RARα−/− samples with that of the 9C-RA–treated WT sample. (C) Quantification in percent of all cells present in gates B and C of immature (gate B in panel A) and mature (gate C in panel A) cells from the experiment displayed in panel B. The experiment described in this figure was performed in duplicate for each of the 2 WT and 2 RARα−/− mice. For a given set of culture conditions and mouse genotype, variations in the percentage of the gated populations were within 1.5% of those indicated.

Close Modal

or Create an Account

Close Modal
Close Modal